Verisense announce opening of Digital Biobank

Natalia Elliot | August 14, 2024 | News story | Research and Development AI, Devices, Diagnostics, Verisense, artificial intelligence, digital health, machine learning 

This week, Verisense have announced that their Digital Biobank, with data from over one million people, is open for business.

The data and digital health technology company have launched their Digital Biobank which will include data from both third parties and Verisense Health Research, totaling 570 studies.

Verisense CEO Geoff Gill stated: “For too long, digital health data from thousands of studies from around the world have been virtually impossible to access. As a result, researchers have had to collect the same or similar data over and over at great cost in time and money.”

Advertisement

The Digital Biobank includes specific medical data which can be used to identify algorithms and digital biomarkers, allowing for comparisons between data to show emerging trends for specific diseases. The data collected come from measurements such as heart rate, respiration, blood pressure, accelerometry, electrocardiogram photoplethysmography, polysomnography, electromyography, electrooculography and galvanic skin response sensors.

“Our goal is for researchers never to have to collect the same data twice,” Geof Gill added

The Digital Biobank utilises an AI-powered Dataset Cataloger, which extracts and catalogues relevant metadata in an efficient manner from open-source digital health datasets. The AI Dataset Cataloger is an automated the process, enabling Verisense Health to update the Verisense Digital Biobank frequently.

Natalia Elliot

Related Content

Liverpool launches £20m lab for infectious disease drug discovery

A new £20m high-security laboratory using robotics, artificial intelligence (AI) and human organoids to accelerate …

AI in pharma: From lab development to patient impact

In the decade to 2025, AI use in vaccine development has increased markedly but is …

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

Bioptimus has partnered with Cancer Research Horizons, the innovation arm of Cancer Research UK, to …

The Gateway to Local Adoption Series

Latest content